Loblaw Companies Limited (L) Earnings Call Transcript & Summary
May 6, 2026
What were the key takeaways from Loblaw Companies Limited's May 6, 2026 earnings call?
Loblaw Companies Limited reported strong first-quarter results for 2026, with revenue growth of 4.2% year-over-year, reaching $14.8 billion. Adjusted diluted EPS increased by 10.6%, reflecting solid operational performance and strategic investments. Management maintained a positive outlook for the year, indicating that performance should closely resemble Q1 results, despite anticipated pressures from new store openings and ongoing investments in technology and distribution centers.
What topics did Loblaw Companies Limited cover?
- Revenue Growth: Loblaw achieved a revenue increase of 4.2% year-over-year, amounting to $14.8 billion. Management noted, 'Our business continues to perform well, reflecting our ongoing focus on Retail excellence.'
- Earnings Performance: Adjusted diluted EPS grew by 10.6%, with GAAP diluted EPS at $0.50, up 19%. Richard Dufresne stated, 'I'm pleased to report another quarter of consistent financial and operational performance.'
- Store Openings and Expansion: The company opened 13 new stores in Q1, including 5 Hard Discount locations. Per Bank emphasized, 'Our strategic and deliberate investment in opening new stores are clearly resonating with Canadians.'
- Pharmacy and Healthcare Growth: Pharmacy same-store sales grew by 6.7%, driven by specialty prescription growth. Management highlighted, 'Our Specialty Prescription growth continued to lead our Pharmacy performance.'
- Cost Management: Retail SG&A improved by 40 basis points, attributed to operating leverage from higher sales. Dufresne noted, 'I'm very pleased with our ability to reduce this rate despite the additional costs associated with opening new stores.'
What were Loblaw Companies Limited's May 6, 2026 results?
- Revenue: $14.8B (vs $14.2B est, +4.2% YoY)
- Adjusted EPS: $0.50 (beat by $0.05)
- Adjusted EBITDA: $1.7B (+6% YoY)
- Same-Store Sales Growth (Food): 2.4% (normalized for right-hand side impact)
- Same-Store Sales Growth (Drug Retail): 4.1% (strong performance in pharmacy)
- Retail Gross Margin: 31.4% (stable YoY)
Loblaw's strong Q1 performance and positive outlook indicate resilience in a challenging retail environment. Key growth drivers include new store openings, pharmacy expansion, and effective cost management. Investors should monitor consumer behavior trends and the impact of new store contributions on earnings as potential catalysts or risks moving forward.
Earnings Call Speaker Segments
Good morning, everyone, and thanks for joining us for the Loblaw Companies Limited conference call on our 2026 first quarter results. Today is Wednesday, May 6, 2026, and this call is being recorded. Once the speakers have finished their remarks, we'll open things up for a question-and-answer session. We ask that you keep yourself to one question, plus one follow-up if you need it. Thank you. If you'd like to ask something at that point, just press star and then the number one on your telephone keypad to raise your hand and join the queue. Should you wish to withdraw your question at any time, simply press star, one once more. I'll now hand the conference over to Roy MacDonald, Vice President, Investor Relations.
All right, thank you so much, Colby, and good morning to everyone. It's a pleasure to welcome you to the Loblaw Companies Limited conference call covering our first quarter 2026 results. Per Bank, our President and CEO, is here with me this morning as always, along with Richard Dufresne, our CFO. Before we get started, I'd like to remind everyone that this discussion today will contain forward-looking statements, and those may cover — without being limited to — statements about Loblaw's expected results in the future. Such statements rest on assumptions and represent management's present expectations. Consequently, they carry a variety of risks and uncertainties that might lead actual results or events to differ materially from what was expected. Those risks and uncertainties get discussed in materials the company has filed with Canadian securities regulators. Forward-looking statements speak only as of the date on which they are made, and the company disclaims any intention or obligation to update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as the law requires. In addition, certain non-GAAP financial measures could be discussed or referred to today; please see our annual report and other materials filed with the Canadian securities regulators for a reconciliation of each of these measures to the most directly comparable GAAP financial measure.
You should also be aware that, after the previously announced divestiture of PC Financial to EQ Bank along with the partnership we continue to maintain, PC Financial's results now appear within discontinued operations. It's worth stressing that exiting the financial services sector is not what we're doing. Therefore, except where stated otherwise, today's comments will center on the comparable total adjusted consolidated results. With that said, Richard will take it from here.
Thanks, Roy, and good morning to everyone. I'm happy to share that we've delivered yet another quarter of steady results across both financial and operational measures, building on the momentum we generated last year. 2026 has begun strongly. Our business keeps performing well, which reflects the continued emphasis we place on retail excellence and our dedication to providing value, quality, service, and convenience to Canadians. During the first quarter, revenue growth came in strong at 4.5% on a normalized basis, adjusting for the exit of our optical business and the divestiture of Wellwise. That top-line growth was complemented by 13 store openings during the first quarter — 8 Shoppers and 5 hard discount — located in underserved communities. Adjusted EBITDA for the total company rose 6% to $1.7 billion, and margin improved 20 basis points to 11.5%. Adjusted diluted net earnings per share increased 10.6%. Under GAAP, revenue was up $600 million, or 4.2%, while diluted EPS came to 50 cents, a 19% increase for the quarter. In food retail, we achieved growth in both traffic and basket on a same-store basis. Absolute sales rose 3.9%, and food same-store sales were up 2.4%. The investments we've made in the right-hand side of our stores are producing positive results in apparel and most GM categories. That said, we continue to face pressure in liquor and tobacco.
Once you adjust for the impact on the right-hand side, same-store food sales were up 2.7%. Our internal food inflation measure, which is similar to CPI, remains well below Canada's grocery CPI figure of 4.4%. Shoppers want value, and they are finding it in our stores. That reflects how well our loyalty program, promotional offers, and in-store value are working. Our pushback against unjustified cost hikes from global suppliers has produced results, easing the inflationary pressure on Canadians. You can see this in the inflation we measure at the cash register, which was roughly in line with our same-store sales growth. With consumers still focused on value, our hard discount banners continue to be a major driver of absolute sales growth. We opened 5 new hard discount stores during the quarter and expect to open roughly 30 stores in total this year. We're happy with how our new stores are performing. This quarter's food comparable sales growth includes 28 hard discount stores opened since 2023. On average, those stores are posting double-digit same-store sales growth. We look forward to bringing more No Frills and Maxi stores to more communities throughout Canada. We're also pleased with the momentum and performance of our conventional stores.
That expansion is still being driven by Fortinos, Zehrs, and T&T. Over in drug retail, absolute sales rose 4.8%, and same-store sales were up 4.1%. Same-store sales for pharmacy and healthcare services climbed 6.7%. Specialty prescriptions kept setting the pace for our pharmacy results. Inside that category, GLP-1 sales growth is still outperforming and accelerated further during the quarter. Throughout our pharmacy network, patients keep reacting well to the convenience and broader primary care access we provide via more than 1,800 pharmacies nationwide. We launched 8 new drugstores this quarter and stay on track to open over 30 new locations in 2026. Front store same-store sales rose 1%. Beauty stayed strong, whereas OTC felt the impact of cough and cold season timing plus bad weather. Online sales keep doing well, up 20.3% this quarter. E-commerce results were powered by PCX delivery growth and the smooth integration of third-party delivery options. Retail gross margin came in at 31.4% and held steady. Food margins were flat, but drug retail gross margins declined. That reflected shifts in sales mix among drug retail categories and cough and cold season timing, partly offset by ongoing shrink improvement.
On the retail side, SG&A came in 40 basis points better, mostly thanks to operating leverage from stronger sales as well as timing benefits on certain costs. I'm really happy with how we've managed to bring that rate down, even with the extra costs that come from opening new stores and ramping up our automated DCs. Retail adjusted EBITDA was up 6.5%, and the retail EBITDA margin rose 20 basis points to 11.1%. Our first automated DC in East Gwillimbury is continuing to ramp up nicely. Cost and operational improvements there have both come in ahead of what we planned. We're still pleased with where we stand and expect it to be fully ramped up later this year. Construction of our second automated DC in South Caledon is moving along very well. That project is still on plan, and automation installation is set to begin at the end of this year. Revenue at PC Financial rose 3.9%, helped by higher insurance commission and higher interest income. Adjusted net earnings for the bank were up $9 million, or 40.9%. That was mainly driven by higher revenue and a favorable impact from lower expected credit loss provisions. The sale of PC Financial to EQ Bank that we announced previously has received all required regulatory approvals, and we now expect the deal to close in the third quarter.
This deal has us genuinely enthusiastic, since it broadens what our PC Optimum program can deliver and gives Canadians additional avenues to collect rewards. As we've said before, roughly $600 million in cash will be freed up for Loblaw through this transaction. A share of those proceeds is expected to go toward boosting our buybacks during 2026, with the remainder used to buy EQB shares on the market. Retail segment free cash flow came in strong at $432 million this quarter. We bought back $648 million of common shares and declared a 10% dividend hike — marking our 15th year in a row of increases. Our balance sheet remains solid, and key return metrics keep getting better, as reflected in DBRS's recent upgrade of our credit rating to A (low). Return on equity stands at 26.8%, while return on capital is 12.4%, which speaks to disciplined capital allocation, tight cost control, and a strategy that's proven itself. For the rest of the year, results ought to look much like what Q1 has shown. As noted earlier, 2026 is the year when the East Gwillimbury DC ramp-up and our T&T US investments weigh most heavily on earnings growth.
Even so, we're confident we can hit our guidance for the year, just as we demonstrated in Q1. By concentrating on retail excellence and carrying out our strategic initiatives, we'll keep bringing value to customers and keep rewarding shareholders. At this point I'll hand the call to Per.
Thanks, Richard, and good morning to everyone. It's a real pleasure to share that we've had a strong first quarter for '26, which gives us a robust and successful start to the year. Our financial results came in solid, with strong revenue growth and adjusted EPS growth. I'm delighted that we could pull this off while also making significant investments to grow our pharmacy and discount presence, expand our T&T banner into the US, and advance two new technology-enabled distribution centers. What we've achieved reflects successful execution of our strategic priorities and our unwavering focus on the customer. The strategic, deliberate investment we're making in opening new stores is clearly resonating with Canadians. We're listening to what Canadians need and investing where it matters. Day in and day out, our focus stays steadfast on quality, value, service, and convenience for customers throughout our coast-to-coast network. These efforts are clearly resonating, as shown by continued strong customer engagement and increased traffic levels across our business. From the strong performance and continued growth of PC Express delivery to the consistent strength of our pharmacy services, we're demonstrating our commitment to being there where and when our customers need us most. We have momentum in our food retail segment, marked by the contribution from our new store investments and our same-store sales growth.
Higher customer traffic was driven by our strong everyday value proposition, tailored PC Optimum loyalty rewards, and effective promotional activity. The continued standout results from our hard discount banners, Maxi and No Frills, were the primary force behind this achievement, confirming how essential they are in assisting Canadians with affordability. We're also quite happy with how our conventional stores performed, with multicultural and prepared food posting very robust growth. Our conventional locations picked up tonnage and share gains relative to their competitors. Strong e-commerce sales growth was also delivered, driven by PC Express delivery and the successful incorporation of third-party delivery choices. Discount customers contributed substantially to this growth, since they increasingly opt for the ease of delivery, which shows the wide appeal and reach of our digital proposition. Within drug retail, Shoppers Drug Mart and Pharmaprix kept showing resilience and growth. Growth in pharmacy and front store mirrored favorable trends in prescription volumes, specialty drugs, and beauty categories, emphasizing the crucial part our pharmacies and healthcare professionals perform in Canadian healthcare. These results demonstrate the strength of our healthcare services and our dedication to addressing Canadians' changing needs. The strategic investments made throughout retail to broaden and improve our network keep delivering returns.
Over the quarter, we widened what Canadians can get when it comes to nutritious food as well as essential healthcare services. We launched 5 new hard discount stores and 8 new drugstores, which further cements our dedication to being located where Canadians most need us. Modernization efforts also showed clearly through a fresh look for our No Frills banner, highlighted by a new store opening in Komoka, Ontario — a modern design achieved at an efficient build cost. To anyone in the GTA area, I'd encourage you to stop by our newly opened T&T Supermarket in Erin Mills, which we marked with a wonderful opening ceremony that drew a really, really strong turnout from many, many stakeholders. Such investments matter greatly for strengthening our foundation, extending our reach into key growth areas, and offering the best possible shopping choices to our customers. In the last quarter, we rolled out the PC Express integration with OpenAI's ChatGPT, converting recipe searches that used to be dead ends into transactions. Customer adoption has already surpassed plan, and we keep advancing our leadership, with the 2.0 version arriving soon. Earlier this week, we were proud to share that we are partnering with Canadian technology firm Securiti, giving our team a common platform that lets us manage and scale AI machine learning throughout our data infrastructure.
Beyond that, we've begun deploying AI productivity solutions throughout our teams to help with their daily tasks. You'll be hearing more on this front—we're only at the beginning. As a proud Canadian business operating over 2,800 locations with 220,000 colleagues, we stay firmly dedicated to backing the communities we serve and delivering life's everyday essentials to families from coast to coast. Looking forward, our confidence in the '26 outlook holds steady. Our portfolio of businesses is strong and genuinely exceptionally positioned to address Canadians' changing needs and to steer successfully through the macro environment. Once more, I'd like to offer my heartfelt thanks to every one of our colleagues for their steadfast dedication, commitment, and focus on our customers. Their hard work forms the cornerstone of our success. With that, I'll now turn things over for questions. Thank you.
Thank you, Per.
Colby, you have the floor?
Colby, please go ahead.
Thanks. We’re moving into the Q&A portion now. Once more, to pose a question, hit star and then the number one on your phone’s keypad so you can raise your hand and join the queue. Should you wish to take your question back at any point, just press star, one once more. We’ll hold briefly while we put the list together. Our first question is from Irene Nattel at RBC Capital Markets. Your line is open.
Thanks, and good morning to all of you. I was hoping you might describe what you're observing when it comes to shopper behavior in stores, and particularly as the quarter unfolded — when we saw that jump in gas prices, did you notice any meaningful shifts in the ways people are attempting to adjust, and where do we stand in Q2 as of today? Thank you.
Thank you, Irene — that's a really good question, and naturally it's something we're giving plenty of thought to. To be honest, what we're observing at the moment is largely a continuation of the same pattern. We're pushing back against price hikes from our suppliers. So far, we aren't seeing any price increases for that reason. Shoppers are still behaving the way they did during the previous quarter — they keep trading down. For instance, I received an example just this morning about chicken, where our customers are purchasing more of the opening price point chicken and purchasing less of the free-from. The free-from is seeing a double-digit decline, while our opening price point is up, with more growth in chicken. It's the same story with steak. Shoppers are purchasing less steak, but they're purchasing more minced beef. They're continuing to buy more on promotion. Consumer sentiment doesn't concern us, because we genuinely believe that the offering we have right across our entire portfolio plays well to that sentiment. It's more of the same than the last quarter, and that's also borne out by the fact that our internal inflation runs slower than the external inflation.
The sole point I would make, Irene, is that Q1 showed us nothing, since when you actually examine gas prices, there is definitely more of it in Q2. During Q2 we observe a small shift, though nothing material. What Per cited as an example is what we are beginning to see at present, yet the direction of our business keeps heading the same way.
I appreciate that.
Chris Li from Desjardins has the next question. Your line is open. Oh,
Morning, everyone. A few questions, perhaps, about how front store sales performed. I'm curious whether, beyond the factors you cited, that was also affected by any pricing changes you may have implemented to strengthen further the value proposition for consumers at Shoppers? Thanks.
When it comes to Q1 front store sales, several events affected them, and the one you brought up played no part whatsoever. On the bright side, prestige kept performing strongly. An Easter shift contributed a small amount of sales, while the timing of cough and cold, bad weather, and weaker food sales in certain regions held our results back. In the quarter, those negatives outweighed the positives. Looking ahead, my confidence in Shoppers front store performance remains very strong.
Great, thanks. Perhaps one quick follow-up there, Per. I recall you saying earlier that you've run some trials of the new food concept in a number of Shoppers locations. Could you give us an update on how those pilots have been doing up to now?
So what we're up to is that we're bringing roughly 1,500 100 products into the Shoppers front store assortment, where we're running a relay. As things stand, we've completed the first three tests. That's just three so far, and we've agreed to run another 40. By the end of next quarter, I'm confident we'll be able to share some insight with you on those 40. Should that turn out well, we're then set to roll it out across a significant number of stores, and if it goes well, it will deliver an uplift for us.
Excellent. Thank you, and best wishes.
Appreciate it.
Mark Carden from UBS has the next question. Your line is open.
Hi, Matthew Rothway here, filling in for Mark Carden. Thanks for taking our questions. I was hoping you could speak to what's driving gross margin a bit. You flagged drug retail mix as a headwind. Could you go into a little more detail on what was behind that?
Actually, that's quite straightforward. Where food is concerned, it stayed flat — okay, really flat, with no change at all from a year ago. As for the drug side, I'd say it was double what we discussed regarding front store items like cough and cold. As you'll recall, we noted that cough and cold landed in December this year, while a year earlier it came in January. This year we didn't achieve the margin we'd had in front store. That's the other point worth bringing up.
Thanks, that's really useful. Just one quick follow-up on SG&A: you said the timing of some costs helped us out this quarter. How should we think about the effect that has on the quarters ahead?
That was a one-off item tied to how the year closed out. A few costs ended up being recorded in Q4 that hadn't been in Q1. So that did give our SG&A rate an improvement, though. Most of the gain, however, came from operating leverage on the back of greater sales.
Perfect — I really appreciate it.
Michael Van Aelst from TD Cowen has the next question. Your line is open.
Morning, and thanks for joining. You mentioned the acceleration in new-store expansion, which has held up quite well across roughly the past 6 quarters. We're aware that new stores typically create a drag, especially during year one, but how far along do you believe you are in that cycle, and when do you expect this push to raise your square footage growth rate to turn more neutral for earnings — perhaps even positive?
This year we opened slightly fewer stores than we did last year, but the situation is largely unchanged. The stores from last year are now part of the base, so they aren't weighing on us any further. Typically, a new discount store becomes profitable within 3, 4, 3, 4, 5 years, depending on where it's located. On new store growth, we're confident that we'll keep building roughly, I don't know, 30 to 40 new No Frills and Maxis each year, and around 70 in total once you include the Shoppers Drug Mart. When we look at what we're doing — and this is why we have so much faith in our plan — we're building in underserved areas. Take as an example that at the start of 2025, we had just one No Frills on Vancouver Island. By the end of this year, we'll have four, and another three have been planned and approved, so that makes eight. Another example: when I started in September 2023, I visited Sudbury of all places, with 166,000 inhabitants. We had zero No Frills there. Today we have two, and they're performing very, very well. It's really, really working for us. Financially, Michael, you're right
That said, the pressure from new stores isn’t the issue anymore. That isn’t what’s holding us back. What’s holding us back right now is basically the ramp-up at East Gwillimbury, which should be finished, let’s say, around Q3, and TNT US. That’s still a drag. What isn’t contributing yet is — as a grocery store takes, I don’t know, 3 years before it begins contributing to earnings — and that will probably start a year or two from now. Once these new stores begin contributing to earnings, this reduced drag is going to turn into a positive. We expect to see that over the next 24 months.
Perfect — that’s exactly the answer I needed. Thanks. So, just so I’m clear about the DC side: at what point do you expect it to stop being a drag and start contributing positively?
You'll see a benefit in the back half of the year. Still, the earnings-per-share drag this year from both TNT US and East Gwillimbury, under our plan, comes to roughly 1%. EPS growth of a bit over 1%. That disappears next year. Then
Once that second DC comes online, will it simply offset the drag we're currently experiencing?
Yes. So in '27 and '28, you get a year of calm, and then in '28 you'll face the same situation we went through with the first one. Hopefully by then our new stores are beginning to contribute to earnings, and the TNT drag will be behind us. We ought to be in a better spot than we are today.
That’s great. I appreciate it.
Vishal Shreedhar from National Bank has the next question — your line is open.
Appreciate you taking my questions. Regarding the repurchase program, you indicated that a portion of the $600 million would go toward buybacks. Compared with the 1.9, how much of that $600 million are we allocating, and what cadence should we expect, considering that Q1 came in stronger than typical?
Vishal, I'd put it this way: we're not there yet, but for your model right now, 2.1 is probably about as good a figure as any to use.
All right, thanks for that. Regarding GLP-1 molecules going generic and the developments that have taken place, could you quantify any revised thinking on how that affects same-store sales growth, when it might start, and what the impact across the P&L looks like and how you see that playing out, to the extent you have better information now?
Honestly, it's premature to say much based on what we know right now. Two manufacturers have gotten the green light, and we previously indicated our expectation was P8 — that's August — for supply to start arriving. It could land a few weeks earlier than that, alright? The honest answer is that once we report Q2, we'll have far more clarity, alright? At that point we can share more granular guidance. We can lay out a trajectory for how the market will take it up, but we'll have a clearer picture. With all of that said, the math is obvious: same-store sales will take a hit, and margin will too. We've discussed the gross margin pressure at Shoppers stemming from sales mix — that's happening because GLP-1 drugs are ramping up at the moment, but once pricing comes down, the effect reverses direction. Pinpointing it today is just too difficult; all I can say is that we're confident in our gross margin, we're confident in our SG&A rate, and when it comes to how generic drugs will affect the top line once they hit the market, your guess is as good as mine.
I'd say this is genuinely great news for Canadians, since they'll be able to get this drug at a far lower cost. Depending on the dose, it's roughly $350 today, and we don't know for certain yet, but the price could possibly come down to a third. It's certainly going to act as a tailwind for us, and it has been growing at about 40% year to date, which is substantial, and just consider the growth once the price becomes far lower. Again, as Richard mentioned, at this point we can only speculate, but it will undoubtedly rise. Again, we look forward to sharing more details with you next quarter.
All right, thanks for that.
Mark Petrie from CIBC has the next question in the queue. Your line is open.
Thank you. Good morning. I actually just wanted to build on the questions Michael was asking about what we spend on stores, and I know you've been focused on finding efficiencies in that upfront investment. I believe you brought that up in connection with the new No Frills format. I was hoping you might be able to put some numbers on it. What impact does that have on the economics and on the payback?
It really comes down to something straightforward. Any dollar we shave off construction costs pushes our IRR higher. As we've mentioned before, we've been putting serious effort into this. Over the past 10 years, construction costs have climbed substantially, but refrigeration is one of the major categories for us, and we've identified ways to lower refrigeration expenses. We're looking for methods to build stores more quickly using semi-assembled panels, which shortens the timeline and thereby lowers the cost, and we're also piloting several other initiatives that could bring it down further still. What I'd like you to take away is that this is an unrelenting focus — we're pleased with where we stand, but we're not content. We continue to work at it, and we want to find ways to bring it down even more, so we can simply generate additional IRRs and enable stores that produce strong returns with a lower starting sales threshold.
Consider that, and once we bring the build cost down—which is what we've accomplished, with Richard's team having done so up to this point—we can move into smaller towns whose catchment areas are significantly lower than today and still achieve the same IRR. That means access to discount stores nationwide will grow, and this essentially reinforces our strategy.
Mark, we're extremely pleased with how all our new stores have performed. As we mentioned, we've opened quite a few since the year began, and every single one of them is performing really well. From our standpoint, we simply keep moving forward here.
Right. It's really about opening up more markets you can reach, rather than necessarily making the paybacks better or significantly better. Can you quantify it at all, or maybe just give us a rough ballpark sense of how much construction costs have come down thanks to all your efforts so far compared with, say, 3 years ago?
Even without giving a specific dollar figure, I'd say that to this point we've managed to bring construction costs down by 30%.
On your other question, it isn't just a matter of expanding. It's also a matter of boosting the IRR in the spots where we're able to add new stores, and it isn't solely about moving into smaller catchments. There are also plenty of locations with large catchment areas where additional discount stores can be built. Again, to return to Sudbury as an example: in a city of 166,000 inhabitants, we have just two stores, and there are very many places comparable to that.
Right, got it. Fine. Thanks for all of that. Best of luck.
I appreciate that.
Etienne Ricard from BMO Capital Markets is your next questioner, and your line is open. Hello, good morning. Emily here, sitting in for Etienne. We appreciate you taking our questions. I'd like to bring the focus back to whatever differences exist between discount and conventional. We're aware that growth in discount is really what's driving sales. Are you noticing any behaviors that differ within each of them, and are you seeing more or less trade-down in discount versus conventional?
Things remain largely unchanged, and we're seeing positive results in both our conventional and discount segments. Comps in the discount business are considerably above those in the conventional business, yet they still aren't speeding up. Shoppers continue to be cautious. As I mentioned earlier, perhaps there's more of a shift toward conventional price points for chicken and similar items; free-from and organic berries could post a decline, while conventional berries are on the rise. Purchases are increasingly promotion-driven. It's essentially the same mechanism our customers are employing, but we aren't seeing it grow. It's more of the same.
I’d like to add that our conventional business is still quite healthy. When we look at same-store results and overall growth—even though we’re barely adding any square footage, if at all—that business keeps performing very well for us. That, together with strong growth in our hard discount business—which is expanding quickly because we’re opening stores on top of stronger same-store performance—is helping us produce the results you’re seeing today. Okay. Just as a follow-up, how would you compare competitive dynamics in Quebec with those in other provinces, and are you seeing any better or worse contribution from new stores in Quebec versus the other jurisdictions? The Quebec market is just as competitive as the rest of the country, so we’re very pleased with how our stores in Quebec are performing, as we are with all of our stores across the country. No notable differences. Thank you.
The next person in the queue is John Zamparo from Scotiabank. Your line is now open.
Thanks. Morning, everyone. I'd like to return to the GLP-1 part of the business. I think you mentioned that you're seeing acceleration there and that Shoppers is gaining share, and that's before any generics were announced. I'm curious what you'd credit that to. Clearly, it's a dominant player across the country, but is there anything you can share about why you believe share has risen so much, and whether that comes from any deliberate efforts or investments on Shoppers' part?
I’m not sure if we actually said we were gaining share on GLP-1. We’re probably growing at 40%, though we lack the same Nielsen data that we have for food, so we can’t state it with exact certainty—but we are seeing a meaningful increase in GLP-1. Not share gain, but sales growth.
Honestly, I couldn't tell you the reason. Seeing growth speed up in Q1 caught us off guard. Like you mentioned, we don't even have a generic version on the market yet, so.
Yeah. Okay, got it. So returning to how the consumer is doing, and specifically the trade-down metrics—thanks for the detail on discount versus conventional. Could you share anything more on promotional intensity and on how national brands are performing relative to private label?
Yes. On our own brands, I’m still seeing outperformance. They’re performing extremely well, and we’ve sharpened our emphasis on our PC and No Name. We’re getting good results there, and customers like it. When they want to save money and get better quality, it’s a solid alternative to the brands.
Much appreciated.
Since there are no more questions waiting, I’ll hand the conference back to Roy MacDonald so he can give the closing remarks.
Thanks a lot, everyone, for spending part of your morning with us. Should anything else come to mind afterward, feel free to send me an email or ring me up. And do put Thursday, July 23 on your schedule — that's when our Q2 results will come out. Have a wonderful day.
That brings us to the end of today's conference call. You're welcome to disconnect at this time.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Loblaw Companies Limited transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Loblaw Companies Limited earnings transcripts and 132,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.